Status:
RECRUITING
Efficiency of Virtual Reality Exposure Therapy in the Management of Body Dysmorphic Disorders in Female Adolescents With Anorexia Nervosa
Lead Sponsor:
CHU de Reims
Conditions:
Anorexia Nervosa
Eligibility:
FEMALE
13-17 years
Phase:
NA
Brief Summary
Anorexia nervosa is defined in DSM V as a quantitative and qualitative dietary restriction resulting in significant weight loss, intense fear of weight gain, altered weight and body shape perception (...
Detailed Description
The aim of this study is to evaluate the effectiveness of Virtual Reality Exposure Therapy in the management of body dysmorphic disorder in patients with anorexia nervosa, compared to the traditionall...
Eligibility Criteria
Inclusion
- Inclusion criteria :
- Female adolescents aged 13 to 18
- with a diagnosis of anorexia nervosa of all types (including purgative and hyperphagic) according to the DSM-V
- French as first language
- agreed to participate in the study
- parental authority holders accepting her participation in the study
- affiliated to a social security system
- Patients will not be included in the study:
- with a somatic severity criterion:
- Total aphagia
- Body mass index (BMI) \< 14kg/m² for those over 17 years of age, BMI \< 13.2kg/m² for those aged 15-16 and BMI \< 12.7kg/m² for those aged 13-14.
- Confusion
- Bradycardia \<40/min, Tachycardia
- Blood pressure \< 80/50mmHg
- Hypothermia \<35.5°C
- Severe metabolic disorders: hypokalemia \< 2.5 mmol/l, hyponatremia \< 125mmol/l or hypernatremia \> 150 mmol/l, hypophosphoremia \< 0.5 mmol/l
- Acetonuria, hypoglycemia \< 0.6g/l
- Creatinine elevation \> 100micromol/l
- Cytolysis \> 4N
- Leuconeutropenia \<1000/mm3
- Thrombocytopenia \<6000000/mm3
- Suicide attempt in the last month before inclusion
- Receiving benzodiazepine treatment outside the prescription limits.
- Psychotic patients or patients with psychoactive substance addiction according to MINI KID criteria (Sheehan DV et al. Reliability and validity of the Mini International Neuropsychiatric Interview for children and adolescents (MINI Kid). J Clin Psychiatry 2010;71(3):313-326).
Exclusion
Key Trial Info
Start Date :
June 20 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 20 2028
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04107870
Start Date
June 20 2021
End Date
September 20 2028
Last Update
March 8 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Damien JOLLY
Reims, France